You are here:

  1. Home
  2. NICE guidance

Betibeglogene autotemcel for treating transfusion-dependent beta-thalassaemia [ID968]

  • Discontinued
  • Reference number: GID-TA10334
  • Project information
  • Project documents

On this page

  1. Draft guidance
  2. Invitation to participate
  3. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
  4. Notes
  5. Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Documents

Documents created during the development process.

Draft guidance

  • Draft guidance

  • Appraisal consultation document (online commenting)

  • Appraisal consultation document (PDF version) (PDF 169 KB)

    Published:
    11 February 2021
  • Committee papers (PDF 4.44 MB)

    Published:
    11 February 2021
  • Public committee slides (PDF 330 KB)

    Published:
    11 February 2021

Invitation to participate

  • Equality impact assessment (Scoping) (PDF 153 KB)

    Published:
    01 August 2019
  • Final stakeholder list (PDF 181 KB)

    Published:
    01 August 2019
  • Final scope (PDF 184 KB)

    Published:
    01 August 2019
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 264 KB)

    Published:
    01 August 2019

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

  • Draft scope pre referral (PDF 189 KB)

    Published:
    21 June 2019
  • Draft matrix pre referral (PDF 181 KB)

    Published:
    21 June 2019

Notes

  • Note

  • Note

  • Note

  • Note

  • Note

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

  • Draft scope pre referral (PDF 354 KB)

    Published:
    28 March 2018
  • Draft matrix pre referral (PDF 254 KB)

    Published:
    28 March 2018
Back to top